Melvyn T Chow

Melvyn T Chow

UNVERIFIED PROFILE

Are you Melvyn T Chow?   Register this Author

Register author
Melvyn T Chow

Melvyn T Chow

Publications by authors named "Melvyn T Chow"

Are you Melvyn T Chow?   Register this Author

14Publications

398Reads

17Profile Views

Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.

Immunity 2019 Jun 13;50(6):1498-1512.e5. Epub 2019 May 13.

Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2019.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527362PMC
June 2019

Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis.

Oncoimmunology 2015 Sep 2;4(9):e1027468. Epub 2015 Apr 2.

Immunology of Cancer and Infection Laboratory; QIMR Berghofer Medical Research Institute ; Herston, Queensland, Australia ; School of Medicine; University of Queensland ; Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1027468DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570135PMC
September 2015

Chemokines in cancer.

Cancer Immunol Res 2014 Dec;2(12):1125-31

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258879PMC
December 2014

Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome priming.

Eur J Immunol 2014 Jul 29;44(7):2111-20. Epub 2014 Apr 29.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia; Department of Pathology, University of Melbourne, Parkville, Australia; Immunology in Infection and Cancer Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201344329DOI Listing
July 2014

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Nat Immunol 2014 May 23;15(5):431-8. Epub 2014 Mar 23.

1] Cellular Immunity Laboratory, Cancer Immunology Program, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. [2] Department of Immunology, Monash University, Alfred Medical Research and Education Precinct, Prahran, Australia. [3] Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia. [4] Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. [5] School of Medicine, University of Queensland, Herston, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.2850DOI Listing
May 2014

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.

Clin Cancer Res 2013 Oct 19;19(20):5636-46. Epub 2013 Jul 19.

Authors' Affiliations: Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Department of Pathology, University of Melbourne; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville; Department of Immunology, Monash University, Clayton; Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research; and School of Medicine, University of Queensland, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0458DOI Listing
October 2013

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.

Proc Natl Acad Sci U S A 2013 Sep 20;110(36):14711-6. Epub 2013 Aug 20.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1308209110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767556PMC
September 2013

NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.

Cancer Res 2012 Nov 17;72(22):5721-32. Epub 2012 Sep 17.

Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-0509DOI Listing
November 2012

NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma.

Immunol Cell Biol 2012 Nov 25;90(10):983-6. Epub 2012 Sep 25.

Cancer Immunology Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2012.46DOI Listing
November 2012

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

Cancer Res 2012 Aug 2;72(16):3906-11. Epub 2012 Jul 2.

Cancer Genomics and Genetics Laboratory, Cancer Immunology Program, and Metastasis Research Group, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-3873DOI Listing
August 2012

Role of γδ T cells in α-galactosylceramide-mediated immunity.

J Immunol 2012 Apr 12;188(8):3928-39. Epub 2012 Mar 12.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1103582DOI Listing
April 2012

Inflammation and immune surveillance in cancer.

Semin Cancer Biol 2012 Feb 24;22(1):23-32. Epub 2011 Dec 24.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2011.12.004DOI Listing
February 2012

Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin.

Immunol Cell Biol 2011 Aug 25;89(6):739-46. Epub 2011 Jan 25.

Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2010.168DOI Listing
August 2011